Results from a large multinational clinical trial (guardian&#8482;3) using prophylactic treatment with turoctocog alfa in paediatric patients with severe haemophilia A: safety, efficacy and pharmacokinetics.

Kulkarni, R; Karim, F A; Glamocanin, S; Janic, D; Vdovin, V; Ozelo, M; Rageliene, L; Carboni, E; Laguna, P; Dobaczewski, G; Seremetis, S; Lindblom, A; Santagostino, E

Results from a large multinational clinical trial (guardian™3) using prophylactic treatment with turoctocog alfa in paediatric patients with severe haemophilia A: safety, efficacy and pharmacokinetics.

Kulkarni, R; Karim, F A; Glamocanin, S; Janic, D; Vdovin, V; Ozelo, M; Rageliene, L; Carboni, E; Laguna, P; Dobaczewski, G; Seremetis, S; Lindblom, A; Santagostino, E.

Afiliação

Kulkarni R; Department of Pediatrics and Human Development, Michigan State University, East Lansing, MI 48824-7106, USA. Roshni.Kulkarni@hc.msu.edu

Haemophilia ; 19(5): 698-705, 2013 Sep.

Article em En | MEDLINE | ID: mdl-23651313

Assuntos

Fator VIII/uso terapêutico; Hemofilia A/tratamento farmacológico; Hemorragia/prevenção & controle; Criança; Pré-Escolar; Fator VIII/efeitos adversos; Fator VIII/farmacocinética; Hemofilia A/metabolismo; Humanos; Lactente; Masculino

Palavras-chave

haemophilia A; paediatric population; pharmacokinetics; prophylaxis; recombinant factor VIII; turoctocog alfa

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fator VIII / Hemofilia A / Hemorragia Tipo de estudo: Clinical_trials Limite: Child / Child, preschool / Humans / Infant / Male Idioma: En Ano de publicação: 2013 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google